Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01794507
Title A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie (prior sponsor, Abbott)
Age Groups: adult
Covered Countries USA | FRA

No variant requirements are available.